Ipratropium & Levosalbutamol Sulphate

Ipratropium & Levosalbutamol Sulphate
R/C IPRATROP DUO  is a combination medication used to treat chronic obstructive pulmonary disease (COPD) and asthma. R/C IPRATROP DUO  contains two active ingredients - Ipratropium and Levosalbutamol Sulphate - that work together to improve breathing and reduce symptoms such as coughing, wheezing, and shortness of breath.
Ipratropium is an anticholinergic medication that works by relaxing the muscles in the airways and improving airflow to the lungs. It blocks certain chemicals that cause the airways to narrow, thereby improving breathing. Levosalbutamol Sulphate is a bronchodilator that works by opening up the airways in the lungs and improving breathing.
R/C IPRATROP DUO is usually taken by inhalation using a metered-dose inhaler or nebulizer. The dosage and frequency of use will depend on the condition being treated and the individual's response to the medication. R/C IPRATROP DUO  is important to follow the dosage instructions provided by a healthcare professional and to use the inhaler or nebulizer properly to ensure optimal delivery of the medication.
Like all medications, R/C IPRATROP DUO may cause side effects, including headache, dizziness, dry mouth, and throat irritation. It may also interact with other medications, so it is important to inform a healthcare professional of all medications being taken.
R/C IPRATROP DUO  is not recommended for use in individuals with certain medical conditions, such as a history of narrow-angle glaucoma or an allergy to any of the ingredients in the medication. Therefore, it is important to inform a healthcare professional of any medical conditions before using this medication.
For further information please contact:
info@sterispharma.com